107 related articles for article (PubMed ID: 4061373)
21. Southwest Oncology Group study of Mitoxantrone for treatment of patients with advanced squamous cell carcinoma of the head and neck.
Mattox DE; Clark GM; Balcerzak SP; O'Bryan RM; Oishi N; Stuckey WJ
Invest New Drugs; 1984; 2(4):405-7. PubMed ID: 6511243
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.
Slayton RE; Creasman WT; Petty W; Bundy B; Blessing JA
Cancer Treat Rep; 1979; 63(11-12):2089-92. PubMed ID: 526942
[No Abstract] [Full Text] [Related]
23. [Experiences with VP-16 in combination with cyclophosphamide or adriamycin in the anaplastic, predominantly small cell bronchogenic carcinoma].
Schmieder HA; Jungi WF; Mayr AC; Senn HJ
Schweiz Med Wochenschr; 1979 Jun; 109(22):841-4. PubMed ID: 462156
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of VP-16-213 in advanced ovarian carcinoma.
Hillcoat BL; Campbell JJ; Pepperell R; Quinn MA; Bishop JF; Day A
Gynecol Oncol; 1985 Oct; 22(2):162-6. PubMed ID: 4054715
[TBL] [Abstract][Full Text] [Related]
25. Phase II trial of mitoxantrone in head and neck carcinoma.
Sridhar KS; Hussein AM; Benedetto P; Waldman SM; Feun LG; Savaraj N; Richman SP; Ardalan B; Desai P
Am J Clin Oncol; 1991 Aug; 14(4):298-304. PubMed ID: 1650529
[TBL] [Abstract][Full Text] [Related]
26. [Phase II study of etoposide (NK 171) in advanced hematological malignancies].
Yoshida T; Nakanishi J; Ito K; Kobayashi S; Ohtake S; Nakamura S; Hattori K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1579-84. PubMed ID: 6476835
[TBL] [Abstract][Full Text] [Related]
27. VP-16 and adriamycin in patients with advanced breast cancer.
Vaughn CB; Maniscalco-Greb E; Lockhard C; Groshko G; Enochs K; Duffin H; Demitrish M
Am J Clin Oncol; 1982 Oct; 5(5):505-9. PubMed ID: 6897491
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of etoposide in previously untreated squamous cell carcinoma of the head and neck.
Cobleigh MA; Hill JH; Lad TE; Shevrin DE; Applebaum EL
Cancer Treat Rep; 1987 Mar; 71(3):321-2. PubMed ID: 3815398
[No Abstract] [Full Text] [Related]
29. [Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
Kimura K; Yamada K; Yoshida T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):496-501. PubMed ID: 3954373
[TBL] [Abstract][Full Text] [Related]
30. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
[TBL] [Abstract][Full Text] [Related]
31. VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer.
Evans WK; Feld R; Osoba D; Shepherd FA; Dill J; Deboer G
Cancer; 1984 Apr; 53(7):1461-6. PubMed ID: 6321006
[TBL] [Abstract][Full Text] [Related]
32. A phase II study of oral VP-16-213 in non-seminomatous testicular cancer.
Cavalli F; Klepp O; Renard J; Röhrt M; Alberto P
Eur J Cancer (1965); 1981 Feb; 17(2):245-9. PubMed ID: 7262161
[No Abstract] [Full Text] [Related]
33. [A phase II clinical trial of oral VP 16-213 in advanced non-Hodgkin's lymphoma].
Nakada H; Ogawa M; Ingaki J; Horikoshi N; Inoue K; Usui N; Adachi K; Tada A; Yamazaki H; Mukaiyama T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1644-8. PubMed ID: 6476837
[TBL] [Abstract][Full Text] [Related]
34. Phase II study with etoposide in previously untreated advanced breast cancer.
Wander HE; Rauschning W; Meyer D; Achterrath W; Nagel GA
Cancer Chemother Pharmacol; 1989; 24(4):261-3. PubMed ID: 2752508
[TBL] [Abstract][Full Text] [Related]
35. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD
Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694
[No Abstract] [Full Text] [Related]
36. Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer.
Perry MC; Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Treat Rep; 1976 Sep; 60(9):1247-50. PubMed ID: 797447
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of etoposide in the treatment of esophageal carcinoma.
Coonley CJ; Bains M; Heelan R; Dukeman M; Kelsen DP
Cancer Treat Rep; 1983 Apr; 67(4):397-8. PubMed ID: 6850656
[No Abstract] [Full Text] [Related]
38. Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
Issell BF; Einhorn LH; Comis RL; Lawson RD; Baker LH; Harvey HA; Lanzotti VA; Wampler GL; Daniels JR; Anderson PN
Cancer Treat Rep; 1985 Jan; 69(1):127-8. PubMed ID: 2981617
[No Abstract] [Full Text] [Related]
39. [A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].
Wakui A; Yokoyama M; Takahashi H; Yoshida Y; Sakata Y; Sato S; Kano A; Kawamoto K; Hashimoto S; Konno K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):319-29. PubMed ID: 3947109
[TBL] [Abstract][Full Text] [Related]
40. Aclacinomycin. Phase II evaluation in advanced squamous carcinoma of the head and neck.
Kish JA; Al-Sarraf M
Am J Clin Oncol; 1984 Oct; 7(5):535-7. PubMed ID: 6507374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
